mRNA-LNP vaccination orchestrates systemic immunity to control human papillomavirus-positive head and neck squamous cell carcinoma
Ke Qiu(Sichuan University), Jianjun Ren(Sichuan University), Mengli Zhu(Sichuan University), Hai Huang(Chinese Academy of Sciences), Stephan Lang(Essen University Hospital), Yanling Liang(Southeast University), Danni Cheng(Sichuan University), Jadwiga Jabłońska(German Cancer Research Center), Minzi Mao(Sichuan University), Xingchen Peng(Sichuan University), Chuanhuan Jiang(Sichuan University), Yan Wang(Sichuan University), Sisi Wu(Guangzhou Sport University), Yufang Rao(Sichuan University), Xiuli Shao(Sichuan University), Shuai Cheng Li(Chengdu University), Li Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Liu(Jinan University), Huifang Li(Sichuan University), Haiyang Wang(University of North Carolina at Chapel Hill), Geoffrey Liu(Princess Margaret Cancer Centre), Fei Chen(Jining Medical University), Wei Xu(Princess Margaret Cancer Centre), Yao Song(Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital), Yu Zhao(Tufts University), Yongbo Zheng(Sichuan University), Xiangrong Song(Sichuan University), Lan Feng(Sichuan University), Xing Duan(Southeast University)
Cited by 1
Related Papers
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
|Nature|2008|1.3k
First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2020|1.1k
mRNA-based therapeutics: powerful and versatile tools to combat diseases
|Signal Transduction and Targeted Therapy|2022|710
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
|Advanced Functional Materials|2017|297